Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
55.69
+0.47 (0.85%)
At close: Jun 27, 2025, 4:00 PM
55.75
+0.06 (0.11%)
After-hours: Jun 27, 2025, 7:30 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Peptide Therapeutics
434.43M
Log In
Log In
Log In
Log In
Upgrade
Peptide Therapeutics Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
434.43M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade